Heart failure beta-blocker initiation — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Start when clinically stable and euvolaemic, with gradual titration
Evidence-based beta-blockers improve outcomes in heart failure with reduced ejection fraction, but initiation should occur when the patient is stable and not acutely fluid overloaded. Doses are titrated gradually with monitoring of heart rate, blood pressure and symptoms. Starting during decompensation can worsen clinical status. Using the target dose immediately increases intolerance risk.
Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-63